Giacomo Cafaro Selected Research

Macrophage Activation Syndrome

1/2020

COVID-19 as part of the hyperferritinemic syndromes: the role of iron depletion therapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giacomo Cafaro Research Topics

Disease

6	COVID-19 01/2023 - 01/2020
3	Atherosclerosis 12/2023 - 01/2018
3	Rheumatoid Arthritis 10/2022 - 01/2017
3	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 01/2021
2	Infections 01/2023 - 01/2021
2	Rheumatic Diseases (Rheumatism) 01/2023 - 01/2018
2	Virus Diseases (Viral Diseases) 01/2021 - 01/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 01/2023
1	Hypertension (High Blood Pressure) 11/2021
1	Critical Illness (Critically Ill) 01/2021
1	Cryoglobulinemia 01/2021
1	Purpura 01/2021
1	Vasculitis (Vasculitides) 01/2021
1	Leukopenia 01/2021
1	Pathologic Processes 01/2021
1	Lymphoma (Lymphomas) 07/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 07/2020
1	Thrombosis (Thrombus) 07/2020
1	Macrophage Activation Syndrome 01/2020
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2020
1	Iron Overload 01/2020
1	Adult-Onset Still's Disease 01/2020
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2020
1	Lymphopenia (Lymphocytopenia) 01/2020
1	Hyperferritinemia 01/2020
1	Septic Shock (Toxic Shock Syndrome) 01/2020
1	Fibrosis (Cirrhosis) 01/2020
1	Osteoarthritis 01/2019
1	Atherosclerotic Plaque (Atheroma) 01/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Neoplasms (Cancer) 01/2017
1	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2015
1	Rare Diseases (Rare Disease) 12/2014
1	Muscular Diseases (Myopathy) 12/2014
1	Myositis (Idiopathic Inflammatory Myopathies) 12/2014

Drug/Important Bio-Agent (IBA)

2	C-Reactive ProteinIBA 10/2022 - 11/2021
2	Interleukin-6 (Interleukin 6)IBA 05/2020 - 01/2020
2	CytokinesIBA 01/2020 - 01/2019
2	InterleukinsIBA 01/2020 - 01/2019
1	LipidsIBA 12/2023
1	Colchicine FDA LinkGeneric 01/2023
1	AutoantibodiesIBA 01/2023
1	Glutens (Glutelin)IBA 01/2023
1	Methotrexate (Mexate)FDA LinkGeneric 10/2022
1	LDL CholesterolIBA 11/2021
1	Monoclonal AntibodiesIBA 01/2021
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2021
1	GlobulinsIBA 01/2021
1	Neutralizing AntibodiesIBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	Janus Kinase InhibitorsIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Janus KinasesIBA 01/2021
1	AntibodiesIBA 07/2020
1	Immunoglobulin A (IgA)IBA 07/2020
1	Immunoglobulin G (IgG)IBA 07/2020
1	Immunoglobulin M (IgM)IBA 07/2020
1	Rheumatoid FactorIBA 07/2020
1	Antiphospholipid AntibodiesIBA 07/2020
1	Interleukin-1 Receptors (Interleukin 1 Receptor)IBA 01/2020
1	Antirheumatic Agents (DMARD)IBA 01/2020
1	Ferritins (Ferritin)IBA 01/2020
1	IronIBA 01/2020
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020
1	Immunomodulating AgentsIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Interleukin-17 (Interleukin 17)IBA 01/2019
1	AlarminsIBA 01/2019
1	ElementsIBA 01/2019
1	Biomarkers (Surrogate Marker)IBA 01/2018
1	Insulin-Like Growth Factor Binding Protein 6IBA 01/2017
1	Chemotactic FactorsIBA 01/2017
1	Insulin-Like Growth Factor II (Somatomedin A)IBA 01/2017
1	Insulin-Like PeptidesIBA 01/2017
1	Ustekinumab (CNTO 1275)FDA Link 01/2015

Therapy/Procedure

5	Therapeutics 01/2023 - 12/2014
1	Precision Medicine 01/2022
1	Injections 01/2019
1	Biological Therapy 01/2018
1	Drug Therapy (Chemotherapy) 01/2015